Regranion, LLC
Contact Us - Regranion
Mount Pleasant, United States · Founded 2017
- Headquarters
- Mount Pleasant, South Carolina
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Website
- regranion.com
About
Regranion is a clinical-stage biopharmaceutical company developing HSP90 inhibitors for immune-mediated skin diseases. Its lead compound RGRN-305 has completed Phase 2 clinical trials for hidradenitis suppurativa and atopic dermatitis, and MC2 Therapeutics acquired an option to license RGRN-305 in 2023.
Summary
Regranion, LLC is a Biotech company based in Mount Pleasant, United States, founded in 2017.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/regranion-llc"><img src="https://indexed.vc/api/badge/company/regranion-llc" alt="Regranion, LLC on Indexed.vc" width="260" height="76" /></a>